Physician profile
Ron Leong
NPI 1851738538
$887.64
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $142 · 2020: $165 · 2021: $232 · 2022: $349.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Portola Pharmaceuticals, LLC | $266.93 | 2019-2020 | |
| Abiomed | $189.82 | 2020-2022 | |
| Terumo Cardiovascular Systems Corporation | $136.96 | 2022 | |
| Atricure, INC. | $78.90 | 2022 | |
| Chiesi USA, INC. | $57.81 | 2021-2022 | |
| Abbott Laboratories | $46.88 | 2021 | |
| Nxstage Medical, INC. | $43.83 | 2022 | |
| Edwards Lifesciences Corporation | $30.09 | 2022 | |
| Boston Scientific Corporation | $19.69 | 2021 | |
| Ge Healthcare | $16.73 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ron Leong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.